BMP Sunstone — Shareholder Meeting (April 2008)
21 slides from BMP Sunstone's shareholder meeting presentation, Apr 28, 2008
Slide 1: Annual Shareholder Meeting April 28, 2008
ANNUAL SHAREHOLDER MEETING April 28, 2008 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement 3 This presentation contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements convey our current expectations or forecasts of future events. All statements other t
Slide 3: Our Corporate Mission
5 Our Corporate Mission BMP Sunstone, a U.S. public company, provides a single source for market evaluation, product registration, marketing, sales and distribution for high value, niche focused Rx and OTC pharmaceutical products in China.
Slide 4: BMP Sunstone: Today and Tomorrow
BMP Sunstone: Today and Tomorrow 2007: A Transformative Year Enhanced Team Operational Highlights Financial Results Investor Relations Recent Achievements BMP Sunstone Today Growth Strategy 2008 Goals Questions 7
Slide 5: Enhanced Corporate Structure
BMP Sunstone Corp. David Gao, CEO Zhiqiang Han , President US/China Enhanced Corporate Structure Beijing Medpharm Byron Wang General Manager (Beijing) Sunstone Pharma Zhiqiang Han General Manager (Tangshan) BMP Sunstone, China Yanping Zhao Corp. VP, Chief Rep (Beijing) Wanwei Pharma Yong Guo General
Slide 6: Key Additions to Senior Management
Key Additions to Senior Management Zhiqiang Han, President Founder of Sunstone Prior executive management experience MBA - Dalian University of Technology 11 Yanping Zhao, Vice President VP and Chief Representative, China BioPharmaceutical GM and head of R&D, Hainan Tiger Lily Pharmaceutical Senior
Slide 7: Key Additions to the Board of Directors
Key Additions to the Board of Directors Mr. Zhiqiang Han joined Feb., 2008. Founder of Sunstone Prior executive management experience 13 Mr. Zhijun Tong joined Feb., 2008. Co-founder of Sunstone Chairman of Qifa Mr. George Bickerstaff joined April, 2008. Managing Director & Partner, CRT Capital Form
Slide 8: Enhanced Product Portfolio
15 Enhanced Product Portfolio
Slide 9: BMP China: The Proven Difference
17 Our fully-integrated approach significantly improved sales volume immediately. Units Note: Propess was initially licensed to a top three Chinese pharmaceutical distribution organization Propess? Anpo ? BMP Took Over BMP Took Over BMP China: The Proven Difference 2004 2005 2006 2007 2005 2006 2007
Slide 10: Solidified Distribution Platform
19 BMP Sunstone is integrating distribution capabilities in Beijing, Shanghai and Guangzhou through select acquisitions and a JV. Beijing: Wanwei (2005) > 85 employees (including 30 sales reps) > Relationships with all top-tier Beijing hospitals > Relationships with 120 distributors > 400 products S
Slide 11: Acquired Sunstone Company Profile
21 Company Profile Headquarters: Tangshan, Hebei Province Strong financial results and profitable: $42.0 million revenue in 2007 $7.3 million net income in 2007 $35.9 million revenue in 2006 Three nationally recognized brand families: "GoodBaby(r)" - Certified Famous Chinese Brand / Pediatric OTC Gr
Slide 12: Financial Snapshot
23 Financial Snapshot Pro Forma 2007 Revenue up 21% to $73.0 million Gross profit up 28% to $33.1 million, a gross margin of 45.4% Adjusted EBITDA up 38% to $7.7 million (EBITDA plus $5.0 million for FAS123R and Stock Based Compensation) Operating income of $4.6 million excl. stock comp and acquisit
Slide 13: Revenue Mix Shift Drives Profitability
25 Pie chart reflects pro forma twelve months through December . 31, 2007 OTC business reflects Sunstone acquisition Operating and net margins increase significantly as revenue mix changes Distribution alone becomes smaller percentage of overall business Sunstone's OTC presence creates sales opportu
Slide 14: Stock Performance
27 Stock Performance BJGP vs Russell 2000 vs China Peers (TTM) * Index of China peer group of AOB, SCR, SSRX, and TCM
Slide 15: Enhanced IR Efforts
Enhanced IR Efforts Successfully increased buyside exposure Buyside target list created Investor conferences Company presented at in 2007-2008: UBS, Merrill Lynch, Goldman Sachs, Credit Suisse, ICR Asia, Roth, Brean Murray, Susquehanna Upcoming conferences: CIBC/OPCO, Jefferies, Susquehanna, ICR Asi
Slide 16: Recent Achievements
31 Sunstone acquisition completed and name changed MOFCOM approval received for Rongheng acquisition Completed GP Corp. JV Secured licensing agreements with world-renowned companies such as Apotex, KV Pharmaceutical and Novartis BMP Sunstone included in NASDAQ Biotech Index Enhanced senior managemen
Slide 17: BMP Sunstone Today
33 We are integrating various operations to expand our reach and enhance revenue and profitability. Beijing Shanghai Guangzhou Marketing & distribution in China's most exciting healthcare markets including: Beijing, Shanghai and Guangzhou Commercialization capabilities now in both hospitals and phar
Slide 18: Growth Strategy
Continue to grow the existing business Expand penetration in hospitals covered Increase number of hospitals covered Increase Sunstone product market penetration Expand product portfolio Therapeutic focus on women's health & pediatrics Continue to license drugs from leading pharmaceutical companies A
Slide 19: 2008 Goals
37 2008 Goals Increase revenues and expand gross margins Maintain strict expense control Secure exclusive drug licenses Maximize the synergy between the businesses Improve internal management process for both operation and financial management Identify and secure additional M&A opportunities Continu
Slide 20: Questions
39 Questions
Slide 21: Annual Shareholder Meeting April 28, 2008
ANNUAL SHAREHOLDER MEETING April 28, 2008 41